Fluoxetine is an anxiolytics drug and also inhibitor of serotonin reuptake [36], our new findings of its effects on Cav3.1 expression and burst firing put forward a possible mechanism explaining its anxiolytic effect, and also broaden its use in the intervention of metabolic disorders. Here, CACNA1G is linked to metabolic disease.